Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation

A. Cinkajzlova, Z. Lacinova, J. Klouckova, P. Kavalkova, P. Trachta, M. Kosak, D. Haluzikova, H. Papezova, M. Mraz, M. Haluzík,

. 2017 ; 42 (1) : 22-30. [pub] 20160502

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013896

Grantová podpora
NT13299 MZ0 CEP - Centrální evidence projektů
NV15-26854A MZ0 CEP - Centrální evidence projektů
NV15-27863A MZ0 CEP - Centrální evidence projektů

AIM OF THE STUDY: Angiopoietin-like protein 6 (ANGPTL6) is a circulating protein with a potential role in energy homeostasis. The aim of the study was to explore the changes in ANGPTL6 levels in patients with obesity (Body mass index, BMI > 40 kg/m(2)) with and without type 2 diabetes mellitus (T2DM) undergoing dietary intervention (very low calorie diet - VLCD) and in a subgroup of T2DM patients after bariatric surgery. Additionally, we examined changes in ANGPTL6 in anorexia nervosa (AN) patients at baseline and after partial realimentation. We also explored the changes in ANGPTL6 mRNA expression in subcutaneous adipose tissue (SAT) of obese subjects. MATERIALS AND METHODS: The study included 23 non-diabetic obese patients, 40 obese patients with T2DM (27 underwent VLCD and 13 underwent bariatric surgery), 22 patients with AN, and 37 healthy control subjects. RESULTS: ANGPTL6 levels of AN patients were increased relative to the control group (68.6 ± 9.9 ng/ml) and decreased from 110.2 ± 13.3 to 73.6 ± 7.1 ng/ml (p = 0.004) after partial realimentation. Baseline ANGPTL6 levels in patients with obesity and T2DM did not differ from the control group. VLCD decreased ANGPTL6 levels only in obese patients with T2DM. Bariatric surgery induced a transient elevation of ANGPTL6 levels with a subsequent decrease to baseline levels. ANGPTL6 mRNA expression transiently increased after bariatric surgery and returned to baseline levels after 12 months. CONCLUSIONS: Collectively, our data suggest that serum ANGPTL6 levels and ANGPTL6 mRNA expression in SAT are affected by metabolic disorders and their treatment but do not appear to directly reflect nutritional status.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013896
003      
CZ-PrNML
005      
20201019162716.0
007      
ta
008      
170413s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/07435800.2016.1169544 $2 doi
035    __
$a (PubMed)27135654
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Cinkajzlová, Anna $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0228108
245    10
$a Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation / $c A. Cinkajzlova, Z. Lacinova, J. Klouckova, P. Kavalkova, P. Trachta, M. Kosak, D. Haluzikova, H. Papezova, M. Mraz, M. Haluzík,
520    9_
$a AIM OF THE STUDY: Angiopoietin-like protein 6 (ANGPTL6) is a circulating protein with a potential role in energy homeostasis. The aim of the study was to explore the changes in ANGPTL6 levels in patients with obesity (Body mass index, BMI > 40 kg/m(2)) with and without type 2 diabetes mellitus (T2DM) undergoing dietary intervention (very low calorie diet - VLCD) and in a subgroup of T2DM patients after bariatric surgery. Additionally, we examined changes in ANGPTL6 in anorexia nervosa (AN) patients at baseline and after partial realimentation. We also explored the changes in ANGPTL6 mRNA expression in subcutaneous adipose tissue (SAT) of obese subjects. MATERIALS AND METHODS: The study included 23 non-diabetic obese patients, 40 obese patients with T2DM (27 underwent VLCD and 13 underwent bariatric surgery), 22 patients with AN, and 37 healthy control subjects. RESULTS: ANGPTL6 levels of AN patients were increased relative to the control group (68.6 ± 9.9 ng/ml) and decreased from 110.2 ± 13.3 to 73.6 ± 7.1 ng/ml (p = 0.004) after partial realimentation. Baseline ANGPTL6 levels in patients with obesity and T2DM did not differ from the control group. VLCD decreased ANGPTL6 levels only in obese patients with T2DM. Bariatric surgery induced a transient elevation of ANGPTL6 levels with a subsequent decrease to baseline levels. ANGPTL6 mRNA expression transiently increased after bariatric surgery and returned to baseline levels after 12 months. CONCLUSIONS: Collectively, our data suggest that serum ANGPTL6 levels and ANGPTL6 mRNA expression in SAT are affected by metabolic disorders and their treatment but do not appear to directly reflect nutritional status.
650    _2
$a angiopoetiny $x krev $7 D042682
650    _2
$a mentální anorexie $x krev $x dietoterapie $x metabolismus $7 D000856
650    _2
$a bariatrická chirurgie $7 D050110
650    _2
$a kalorická restrikce $7 D031204
650    _2
$a diabetes mellitus 2. typu $x krev $x dietoterapie $x chirurgie $7 D003924
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x krev $x dietoterapie $x chirurgie $7 D009765
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lacinová, Zdeňka $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. b Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0062138
700    1_
$a Kloučková, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0232313
700    1_
$a Kaválková, Petra $u a Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0094376
700    1_
$a Trachta, Pavel $u Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0248280
700    1_
$a Kosák, Mikuláš $u Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0105672
700    1_
$a Haluzíková, Denisa, $u c Department of Sports Medicine, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $d 1970- $7 jo2003163140
700    1_
$a Papežová, Hana, $u Department of Psychiatry, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $d 1953- $7 jn20001005414
700    1_
$a Mráz, Miloš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. b Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0119173
700    1_
$a Haluzík, Martin, $u Department of Obesitology , Institute of Endocrinology , Prague , Czech Republic. $d 1970- $7 xx0000707
773    0_
$w MED00001519 $t Endocrine research $x 1532-4206 $g Roč. 42, č. 1 (2017), s. 22-30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27135654 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20201019162715 $b ABA008
999    __
$a ok $b bmc $g 1200361 $s 974674
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 42 $c 1 $d 22-30 $e 20160502 $i 1532-4206 $m Endocrine research $n Endocr Res $x MED00001519
GRA    __
$a NT13299 $p MZ0
GRA    __
$a NV15-26854A $p MZ0
GRA    __
$a NV15-27863A $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Možnosti archivace